Senseonics Holdings, Inc. Appoints Jon D. Isaacson as Chief Financial Officer
January 07, 2019 at 04:10 pm EST
Share
Senseonics Holdings, Inc. announced the appointment of Jon D. Isaacson as the company’s Chief Financial Officer, effective immediately. Concurrently, and as previously announced, R. Don Elsey has stepped down from the position and will continue in an advisory role to ensure an orderly transition and completion of the company’s annual SEC filings for the 2018 fiscal year. Most recently Mr. Isaacson served as Chief Financial Officer of Edelman Financial Services where he was responsible for financial planning and analysis, tax, treasury and corporate development. Prior to this role, Mr. Isaacson was a Managing Director at a private equity firm where he led the East Coast healthcare practice.
Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the diabetes community. Its glucose monitoring (CGM) systems, Eversense, Eversense XL, and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every five minutes to a mobile app on the user's smartphone. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device. Its CGM system continually and accurately measures a person's glucose levels for up to six months.
SENSEONICS HOLDINGS, INC. 
